Replimune Group, Inc. REPL
$18.09
+2.75%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 2 Hold · 1 Sell)
- Average Price Target
- $16.33
- Implied Upside
- -9.7%
- Price Target Range
- $2.00 – $31.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-29 | Leerink PartnersDaina Graybosch |
Maintains | Outperform | $19 → $31 |
| 2026-08-26 | JP MorganAnupam Rama |
Maintains | Overweight | $20 → $21 |
| 2026-08-07 | JP MorganAnupam Rama |
Maintains | Overweight | $17 → $20 |
| 2026-08-07 | WedbushRobert Driscoll |
Upgrades | Neutral → Outperform | $12 → $19 |
| 2026-08-04 | Leerink PartnersJonathan Chang |
Upgrades | Market perform → Outperform | $11 → $17 |
| 2026-07-31 | WedbushRobert Driscoll |
Maintains | Neutral | $9 → $12 |
| 2026-07-31 | Cantor FitzgeraldLi Watsek |
Upgrades | Neutral → Overweight | — |
| 2026-06-30 | WedbushRobert Driscoll |
Maintains | Neutral | $6 → $9 |
| 2026-06-01 | WedbushRobert Driscoll |
Maintains | Neutral | $2 → $6 |
| 2026-04-13 | Cantor FitzgeraldLi Watsek |
Downgrades | Overweight → Neutral | — |
| 2026-04-13 | Leerink PartnersJonathan Chang |
Downgrades | Outperform → Market perform | $11 → $2 |
| 2026-04-13 | JP MorganAnupam Rama |
Downgrades | Neutral → Underweight | — |
| 2026-04-13 | WedbushRobert Driscoll |
Downgrades | Outperform → Neutral | $19 → $2 |
| 2026-04-13 | JefferiesRoger Song |
Downgrades | Buy → Hold | $13 → $2 |
| 2026-04-13 | HC Wainwright & Co.Robert Burns |
Downgrades | Buy → Sell | — |
| 2026-02-05 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $13 → $14 |
| 2026-02-04 | WedbushRobert Driscoll |
Maintains | Outperform | $18 → $19 |
| 2025-11-03 | BMO CapitalEvan David Seigerman |
Upgrades | Underperform → Market perform | $2 → $11 |
| 2025-10-27 | HC Wainwright & Co.Robert Burns |
Upgrades | Neutral → Buy | $12 |
| 2025-10-20 | JP MorganAnupam Rama |
Upgrades | Underweight → Neutral | $11 |
| 2025-10-20 | Leerink PartnersJonathan Chang |
Upgrades | Market perform → Outperform | $3 → $13 |
| 2025-10-20 | WedbushRobert Driscoll |
Upgrades | Neutral → Outperform | $4 → $18 |
| 2025-09-19 | JP MorganAnupam Rama |
Downgrades | Neutral → Underweight | — |
| 2025-09-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Neutral | — |
| 2025-07-30 | Cantor FitzgeraldLi Watsek |
Upgrades | Neutral → Overweight | — |
| 2025-07-23 | BMO CapitalEvan David Seigerman |
Downgrades | Outperform → Underperform | $27 → $2 |
| 2025-07-23 | BarclaysPeter Lawson |
Downgrades | Overweight → Equal-weight | $17 → $3 |
| 2025-07-23 | HC Wainwright & Co.Robert Burns |
Downgrades | Buy → Neutral | — |
| 2025-07-22 | Leerink PartnersJonathan Chang |
Downgrades | Outperform → Market perform | $21 → $3 |
| 2025-07-22 | JP MorganAnupam Rama |
Downgrades | Overweight → Neutral | $19 → $9 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $18.09
- Market Cap
- $1.67 billion
- 52-Week Range
- $1.50 – $18.40
- Average Volume
- 2.37 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.